Chemo-Pharma [CPL] vs Escorts Kubota [ESCORTS] Detailed Stock Comparison

Chemo-Pharma Laboratories Inc.

BSE
Loading...

Escorts Kubota Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Chemo-Pharma Laboratories Inc. wins in 12 metrics, Escorts Kubota Ltd. wins in 7 metrics, with 0 ties. Chemo-Pharma Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Chemo-Pharma Laboratories Inc. Escorts Kubota Ltd. Better
P/E Ratio (TTM) 13.22 27.91 Chemo-Pharma Laboratories Inc.
Price-to-Book Ratio 2.69 3.09 Chemo-Pharma Laboratories Inc.
Debt-to-Equity Ratio 48.02 0.87 Escorts Kubota Ltd.
PEG Ratio 0.42 2.66 Chemo-Pharma Laboratories Inc.
EV/EBITDA 13.60 21.90 Chemo-Pharma Laboratories Inc.
Profit Margin (TTM) 6.53% 21.71% Escorts Kubota Ltd.
Operating Margin (TTM) 11.52% 11.29% Chemo-Pharma Laboratories Inc.
EBITDA Margin (TTM) 11.52% 11.29% Chemo-Pharma Laboratories Inc.
Return on Equity 20.97% 12.21% Chemo-Pharma Laboratories Inc.
Return on Assets (TTM) 11.26% 9.66% Chemo-Pharma Laboratories Inc.
Free Cash Flow (TTM) $41.66M $7.47B Escorts Kubota Ltd.
Dividend Yield N/A 1.02% N/A
1-Year Return -5.34% -11.78% Chemo-Pharma Laboratories Inc.
Price-to-Sales Ratio (TTM) 1.31 3.33 Chemo-Pharma Laboratories Inc.
Enterprise Value $5.40B $299.02B Escorts Kubota Ltd.
EV/Revenue Ratio 1.52 2.71 Chemo-Pharma Laboratories Inc.
Gross Profit Margin (TTM) 24.93% 29.00% Escorts Kubota Ltd.
Revenue per Share (TTM) $62 $1,001 Escorts Kubota Ltd.
Earnings per Share (Diluted) $5.81 $119.61 Escorts Kubota Ltd.
Beta (Stock Volatility) 0.28 0.29 Chemo-Pharma Laboratories Inc.

Chemo-Pharma Laboratories Inc. vs Escorts Kubota Ltd. Stock Performance Analysis

Loading Price Chart...

CPL
ESCORTS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Chemo-Pharma Laboratories Inc.0.43%-0.20%-9.72%10.04%-11.06%-12.31%
Escorts Kubota Ltd.1.44%0.09%-6.64%-8.46%-24.68%-26.68%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Chemo-Pharma Laboratories Inc.-5.34%232.23%82.57%325.71%1,271.09%1,271.09%
Escorts Kubota Ltd.-11.78%26.70%136.03%1,465.42%2,391.11%4,332.42%

Performance & Financial Health Analysis: Chemo-Pharma Laboratories Inc. vs Escorts Kubota Ltd.

MetricCPLESCORTS
Market Information
Market Cap i₹4.62B₹364.07B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i97,700105,794
90 Day Avg. Volume i68,661146,510
Last Close₹70.50₹2,801.10
52 Week Range₹52.67 - ₹87.75₹2,700.00 - ₹4,180.00
% from 52W High-19.66%-32.99%
All-Time High₹128.00 (Jan 06, 2025)₹4,420.00 (Sep 23, 2024)
% from All-Time High-44.92%-36.63%
Growth Metrics
Quarterly Revenue Growth0.40%0.11%
Quarterly Earnings Growth0.41%0.12%
Financial Health
Profit Margin (TTM) i0.07%0.22%
Operating Margin (TTM) i0.12%0.11%
Return on Equity (TTM) i0.21%0.12%
Debt to Equity (MRQ) i48.020.87
Cash & Liquidity
Book Value per Share (MRQ)₹28.58₹1,080.34
Cash per Share (MRQ)₹0.05₹650.78
Operating Cash Flow (TTM) i₹277.99M₹12.38B
Levered Free Cash Flow (TTM) i₹313.23M₹12.65B
Dividends
Last 12-Month Dividend Yield iN/A1.02%
Last 12-Month Dividend i₹0.00₹36.00

Valuation & Enterprise Metrics Analysis: Chemo-Pharma Laboratories Inc. vs Escorts Kubota Ltd.

MetricCPL (Apr 26, 2026)ESCORTS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i13.2227.91
Forward P/E iN/A24.91
PEG Ratio i0.422.66
Price to Sales (TTM) i1.313.33
Price to Book (MRQ) i2.693.09
Market Capitalization
Market Capitalization i₹4.62B₹364.07B
Enterprise Value i₹5.40B₹299.02B
Enterprise Value Metrics
Enterprise to Revenue i1.522.71
Enterprise to EBITDA i13.6021.90
Risk & Other Metrics
Beta i0.280.29
Book Value per Share (MRQ) i₹28.58₹1,080.34

Financial Statements Comparison: Chemo-Pharma Laboratories Inc. vs Escorts Kubota Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCPL (2025)ESCORTS (2025)
Revenue/Sales i2.85B101.10B
Cost of Goods Sold i2.07B73.59B
COGS % of Revenue i72.6%72.8%
Gross Profit i778.98M27.51B
Gross Margin i27.4%27.2%
Research & Development iN/AN/A
Operating Income (EBIT) i300.69M9.27B
Operating Margin i10.6%9.2%
EBITDA i353.29M14.05B
EBITDA Margin i12.4%13.9%
Pre-Tax Income i392.47M13.51B
Pre-Tax Income % of Revenue i13.8%13.4%
Income Tax i79.24M2.27B
Income Tax % of Revenue i2.8%2.2%
Net Income (Profit) i313.23M12.65B
Profit Margin i11.0%12.5%

Balance Sheet & Liquidity Metrics

MetricCPL (2025)ESCORTS (2025)
Cash & Equivalents i12.05M3.43B
Total Current Assets i2.51B71.35B
Total Current Assets % of Revenue i88.1%70.6%
Total Current Liabilities i1.17B24.88B
Total Current Liabilities % of Revenue i41.2%24.6%
Long-Term Debt i109.50M677.40M
Long-Term Debt % of Revenue i3.8%0.7%
Total Shareholders Equity i1.49B103.63B
Retained Earnings i1.08B60.72B
Retained Earnings % of Revenue i37.9%60.1%
Property, Plant & Equipment i48.61M19.81B

Cash Flow Statement Comparison

MetricCPL (2025)ESCORTS (2025)
Operating Cash Flow i277.99M12.38B
Operating Cash Flow % of Revenue i9.8%12.2%
Capital Expenditures i-47.82M-2.14B
Free Cash Flow i41.66M7.47B
FCF Margin i1.5%7.4%
Debt Repayment i-359.80MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCPLESCORTS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i60.18M110.02M
Float Shares i17.41M30.98M
% Held by Insiders i69.98%73.14%
% Held by Institutions i0.00%13.63%
% Held by Public i30.02%13.23%

Dividend Analysis & Yield Comparison: Chemo-Pharma Laboratories Inc. vs Escorts Kubota Ltd.

MetricCPLESCORTS
Last 12-Month Dividend i₹0.00₹36.00
Last 12-Month Dividend Yield iN/A1.02%
3-Year Avg Annual Dividend i₹0.00₹23.67
3-Year Avg Dividend Yield iN/A0.43%
3-Year Total Dividends i₹0.00₹71.00
Ex-Dividend DateN/AFeb 16, 2026